Clinical Trial

Precision Radiotherapy Enabled by Molecular MRI

Recruiting
View on ClinicalTrials.gov →
Summary
This is a research study to determine if a novel molecular magnetic resonance imaging (MRI) technique, called amide proton transfer (APT) imaging, is useful in identifying the most aggressive areas of tumor needed for radiotherapy of brain tumors.
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-07
Trial Details
NCT Number NCT07512154
Lead Sponsor Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators: The Ben & Catherine Ivy Foundation
Conditions Brain Cancer
Enrollment 20 participants
Start Date 2026-04-29
Primary Completion 2031-05 (estimated)
Study Completion 2032-05 (estimated)
Updated on ClinicalTrials.gov 2026-05-06